Every week, there's a new peptide, protocol, or wellness supplement your group chat won't stop talking about. The information is everywhere. The clarity is not.
"Is This Right for Me?" is a new Commune Podcast series built for exactly that moment. Each episode takes one treatment, therapy, or supplement that keeps flooding your feed and does the one thing the internet rarely does: slows down, looks at the actual evidence, and helps you figure out if it makes sense for you specifically.
The first episode tackles GLP-1s. Ozempic, Wegovy, Mounjaro, Zepbound. Jeff breaks down how they work, what the clinical trials actually showed, and what the wellness internet keeps leaving out.
This episode covers:

What GLP-1s are and how they work in the body
The real clinical trial data on semaglutide and tirzepatide
What happens to your weight when you stop taking them
Muscle loss, gallstones, thyroid risk, and side effects worth knowing
Who these drugs make sense for and who they don't
The compounding pharmacy crackdown and what it means for you
What "natural GLP-1s" actually are and aren't
The lifestyle habits that work on the same systems without a prescription

This episode was made possible by:

Beyond BioHacking: Save $400 on any ticket with code COMMUNE400 at beyondconference.com.
Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 15% off your order at vivobarefoot.com/commune.
Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE
Sunlighten: Visit sunlighten.com/commune and use code COMMUNE when you fill out the “Get Pricing’ form to save up to $1,600 on your purchase.
LMNT: Get a free 8-count Sample Pack of LMNT’s most popular drink mix flavors with any purchase at drinklmnt.com/commune.